Pacira Pharmaceuticals buy Wedbush
Start price
08.02.24
/
50%
€25.80
Target price
08.02.25
€53.03
Performance (%)
-0.78%
End price
09.02.25
€25.60
Summary
This prediction ended on 09.02.25 with a price of €25.60. The BUY prediction by Wedbush for Pacira Pharmaceuticals closed nearly unchanged. Wedbush has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Pacira Pharmaceuticals | -8.380% | -8.380% | -33.871% |
| iShares Core DAX® | 0.754% | -1.027% | 14.485% |
| iShares Nasdaq 100 | -2.859% | -4.266% | 2.185% |
| iShares Nikkei 225® | 4.946% | 5.736% | 25.355% |
| iShares S&P 500 | -1.254% | -2.357% | 1.146% |
Comments by Wedbush for this prediction
In the thread Pacira Pharmaceuticals diskutieren
Pacira BioSciences, Inc. (NASDAQ: PCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $57.00 price target on the stock.
Ratings data for PCRX provided by MarketBeat
In the thread Trading Pacira Pharmaceuticals
Die von Wedbush gewählte maximale Laufzeit wurde überschritten